Navigation Links
Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
Date:11/6/2009

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- America's Specialty Medicines Companies (ASMC), an informal working group of mid-market and smaller innovator pharmaceutical companies, today expressed concerns about H.R. 3962, the "Affordable Health Care for America Act," introduced by House Democrats last Thursday. These smaller companies fear that the cumulative effect of a host of provisions in H.R. 3962 will hinder their efforts to bring new medicines to market.

From required rebates to mandated discounts to new regulations, H.R. 3962 repeatedly raises new barriers for small companies seeking to fund life-saving research. Unlike larger companies, smaller companies typically must use cash generated from the sale of their own products for research. Unfortunately, the bill starves them of those necessary revenues. Its new burdens will damage the viability of small companies, and ultimately, put at risk the health of future patients who need medicines that smaller companies are more likely to develop.

Smaller companies generate much of the innovation in the pharmaceutical industry. Their work ranges over the entire spectrum from drugs for some of the most common diseases like cancer and diabetes to those for smaller, underserved populations with rare diseases. Without smaller companies' investment in the research and development of breakthrough products, many patients would go without any effective treatment. In many cases, these very treatments contain costs by eliminating the need for more expensive care.

"Small pharmaceutical companies often bring needed specialty medications to market when no one else will. Unfortunately, H.R. 3962 would stifle that innovation and prevent those efforts. Ultimately, the patients who need these medicines will suffer most," said Steve Cannon, an attorney representing ASMC.

But the damage runs deeper. H.R. 3962 will cut off small drug companies' ability to bring
'/>"/>

SOURCE America's Specialty Medicines Companies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
2. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
3. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
6. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
7. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
8. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
11. VA Statement on Smoking Cessation Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014 Kinex Pharmaceuticals announced today ... at Roswell Park Cancer Institute. KX2-361 (KX02), ... that has shown potent inhibitory activity against a broad ... are resistant to Temozolomide (T98G), the most widely used ... well-established brain tumor mouse model, KX2-361 consistently clears brain ...
(Date:12/24/2014)... and FARMINGTON, Conn. ... Inc. (NYSE MKT: PTN), a biopharmaceutical company developing ... diseases with significant unmet medical need and commercial ... a private placement of 2,050,000 shares of its ... 24,949,325 shares of its common stock.  Funds under ...
(Date:12/24/2014)... Dec. 23, 2014 ResMed (NYSE: RMD ... action against Chinese medical device manufacturer BMC Medical Co., Ltd. ... that BMC,s masks listed below infringe ResMed,s patents, and entered ... masks in the United States : ... mask , Willow nasal pillows mask , iVolve ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... R.I., June 14, 2011 CVS/pharmacy ... options at more than 7,200 convenient locations nationwide. Shoppers have ... a larger-than-ever selection of gifts, goods and everyday needs. From ... offers the hottest gear and thoughtful keepsakes perfect for every ...
... Inc. (NYSE AMEX: ULU), a specialty pharmaceutical ... management and oral care products, today announced it has completed ... Company,s Chairman, President, and Chief Executive Officer. The Company intends ... The convertible notes will bear interest at the rate of ...
Cached Medicine Technology:Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 3ULURU Inc. Raises $140,000 in Convertible Debt Offering 2
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number ... Southern District of West Virginia, Bernstein Liebhard LLP reports. ... the Court is scheduled to convene a Joint Status ... 2015, at 10:00 a.m. Parties have been directed to ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... GlaxoSmithKline (NYSE: GSK ) is prepared with ... Inhalation Powder ( www.RELENZA.com ) to meet public health ... to newly updated influenza activity data ( http://www.cdc.gov/flu/weekly/ ) ... (CDC), the flu virus is widespread in 27 states. ...
... March 2 Join Jacqueline Foreman, host of Your Mental ... best-selling author John Gray whose first book Men Are ... copies worldwide. They will discuss his new book ... Men and Women Cope Differently with Stress on Thursday, ...
... March 2 /PRNewswire/ -- The Healthcare business ... the national healthcare alliance, as its preferred vendor for ... vendor designation, Thomson Reuters is authorized to sell its ... Clinical Xpert has been named the KLAS Category Leader ...
... special protein sequence, the so-called PARF motif, on their ... Singh Chhatwal and his colleague Patric Nitsche-Schmitz of the ... the role played by PARF in the development of ... a test system that is able to recognise and ...
... N.J., March 2 Managed Health Care Associates, Inc. ... announced the launch of a new website www.mhainc.com ... look more representative of MHA,s strong brand and leadership ... the latest information on MHA core businesses and supporting ...
... New CompactRIO Controller and Five FPGA-Based Chassis are Ideal ... Texas, March 2, 2009 National Instruments (Nasdaq: ... prototyping hardware that makes it possible for engineers and ... time to market and lower development costs. The five ...
Cached Medicine News:Health News:Ample Supplies of Relenza Available as Flu Season Peaks 2Health News:Ample Supplies of Relenza Available as Flu Season Peaks 3Health News:John Gray Will Discuss His New Book Why Mars and Venus Collide 2Health News:VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems 2Health News:VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems 3Health News:Help for children with sick hearts 2Health News:MHA Announces: Launch of New Website 2Health News:National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs 2Health News:National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs 3Health News:National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs 4
LOGIQ Book XP provides you the next generation performance in a compact platform....
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
... Guidant VASOVIEW® HemoPro™ EVH system ... new level of performance in ... the saphenous vein and radial ... it lets you make a ...
Patient Monitor...
Medicine Products: